Clinical trials
Completed Phase 1/2 Bronchiolitis Obliterans Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genta Incorporated | 2 |
| H. Lee Moffitt Cancer Center and Research Institute | 2 |
| Pharmacyclics LLC. | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | 1 |
| Banc de Sang i Teixits | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| Dana-Farber Cancer Institute | 1 |
| Edixomed Ltd | 1 |
| Fate Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bronchiolitis Obliterans Syndrome | 30 |
| Graft vs Host Disease | 8 |
| Leukemia | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Hematologic Neoplasms | 2 |
| Immune System Diseases | 2 |
| Lymphoma, Follicular | 2 |
| Neoplasms | 2 |
| Stroke | 2 |
| Arthritis, Rheumatoid | 1 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.